Patents Assigned to SHIN YOKOHAMA KATO CLINIC
  • METHODS OF PREDICTING HOST RESPONSIVENESS TO CANCER IMMUNOTHERAPIES BY EX VIVO INDUCTION OF LEUKOCYTE-FUNCTION-ASSOCIATED mRNAs
    Publication number: 20140147470
    Abstract: Embodiments of the invention relate generally to ex vivo methods of quantifying expression of leukocyte-function associated mRNAs and using the quantification to characterize an individual's potential responsiveness to cancer immunotherapy. Certain embodiments relate to methods to monitor the efficacy of ongoing cancer immunotherapy by evaluating expression of leukocyte-function associated mRNAs genes before and administration of an anti-cancer immunotherapy regimen.
    Type: Application
    Filed: July 18, 2012
    Publication date: May 29, 2014
    Applicants: HITACHI CHEMICAL C., LTD., SHIN YOKOHAMA KATO CLINIC, HITACHI CHEMICAL RESEARCH CENTER, INC.
    Inventors: Masato Mitsuhashi, Yoichi Kato